Isolated limb perfusion as a treatment option for rare types of tumours.
作者： Valerio Belgrano , Ilan Ben-Shabat , Peter Bergh , Roger Olofsson Bagge
DOI: 10.1080/02656736.2016.1188999
关键词:
摘要: AbstractBackground: Isolated limb perfusion (ILP) is an established and effective treatment for advanced melanoma soft tissue sarcomas of the extremities with a high overall response rate. The aim this study was to describe our experience ILP more rare types tumours.Methods: Patients Merkel cell carcinoma (MCC) (n = 4), squamous (SCC) (n = 2), B-cell lymphoma (n = 1), desmoid tumours (n = 3), pigmented villonodular synovitis (PVNS) (n = 1) giant tumour were treated analysed retrospectively.Results: four patients in-transit MCC had three complete responses (CR) one partial (PR); two SCC CR stable disease (SD); PR SD. A also observed patient tumour, but PVNS cutaneous metastases showed CR, however rapid systemic progression. Local toxic...
sci-hub.se 参考文章(23)
S DI GRAZIA, Giant cell tumor of tendon sheath: study of 64 cases and review of literature. Il Giornale di chirurgia. ,vol. 34, pp. 149- 152 ,(2013) , 10.11138/GCHIR/2013.34.5.149
Dirk J. Grünhagen, Johannes H.W. de Wilt, Albertus N. Van Geel, Cornelis Verhoef, Alexander M.M. Eggermont, Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities. Recent results in cancer research. ,vol. 179, pp. 257- 270 ,(2009) , 10.1007/978-3-540-77960-5_16
E. ELHASSADI, E. EGAN, G. O'SULLIVAN, R. MOHAMED, Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T‐cell lymphoma Clinical and Laboratory Haematology. ,vol. 28, pp. 279- 281 ,(2006) , 10.1111/J.1365-2257.2006.00788.X
D.J. Grünhagen, J.H.W. de Wilt, C. Verhoef, A.N. van Geel, A.M.M. Eggermont, TNF-based isolated limb perfusion in unresectable extremity desmoid tumours Ejso. ,vol. 31, pp. 912- 916 ,(2005) , 10.1016/J.EJSO.2005.07.002
D. L. M. van Broekhoven, J. P. Deroose, S. Bonvalot, A. Gronchi, D. J. Grünhagen, A. M. M. Eggermont, C. Verhoef, Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis. British Journal of Surgery. ,vol. 101, pp. 1674- 1680 ,(2014) , 10.1002/BJS.9659
NATHALIE C. ZEITOUNI, CERRENE N. GIORDANO, JOHN M. KANE, In‐Transit Merkel Cell Carcinoma Treated with Isolated Limb Perfusion or Isolated Limb Infusion: A Case Series of 12 Patients Dermatologic Surgery. ,vol. 37, pp. 357- 364 ,(2011) , 10.1111/J.1524-4725.2011.01883.X
Sebastian Kobold, Nerbil Killic, Tim Lütkens, Carsten Bokemeyer, Walter Fiedler, Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg type. Acta Haematologica. ,vol. 123, pp. 179- 181 ,(2010) , 10.1159/000294963
Jan P. Deroose, Dirk J. Grünhagen, Johannes H.W. de Wilt, Alexander M.M. Eggermont, Cornelis Verhoef, Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas. European Journal of Cancer. ,vol. 51, pp. 367- 373 ,(2015) , 10.1016/J.EJCA.2014.11.020
Mathew P. Hughes, Matthew E. Hardee, Lynn A. Cornelius, Laura F. Hutchins, Jurgen C. Becker, Ling Gao, Merkel Cell Carcinoma: Epidemiology, Target, and Therapy Current Dermatology Reports. ,vol. 3, pp. 46- 53 ,(2014) , 10.1007/S13671-014-0068-Z
J. Wieberdink, C. Benckhuysen, R.P. Braat, E.A. Van Slooten, G.A.A. Olthuis, Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. European Journal of Cancer and Clinical Oncology. ,vol. 18, pp. 905- 910 ,(1982) , 10.1016/0277-5379(82)90235-8